About Philochem

Philochem is a fully owned daughter company of Philogen and represents the Discovery Unit of the Philogen group.

Philochem is based in Otelfingen (Zurich, Switzerland) and was founded in 2006, with the mission to innovate ligand discovery and medicinal target identification.

Philochem has discovered innovative methodologies for biotechnology product development...>>

Recent News

Zürich (Switzerland),
3rd March, 2015

Philochem announces the publication in the prestigious journal Nature Chemistry of an article entitled 'Dual-display of small molecules enables the discovery of ligand pairs and facilitates affinity maturation'.
(see full press release)

Upcoming Events

Siena, (Italy),
27th-28th September, 2015

Data from Philogen's Phase Ib clinical trial of Dekavil in rheumatoid arthritis will be presented at the 4th Israel-Italy Meeting of Autoimmunity and Autoinflammation: Cutting Edge.